>
Switch to:

Biohaven Pharmaceutical Holding Co EV-to-Revenue

: 73.39 (As of Today)
View and export this data going back to 2017. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biohaven Pharmaceutical Holding Co's enterprise value is $4,669.50 Mil. Biohaven Pharmaceutical Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $63.63 Mil. Therefore, Biohaven Pharmaceutical Holding Co's EV-to-Revenue for today is 73.39.

NYSE:BHVN' s EV-to-Revenue Range Over the Past 10 Years
Min: 61.43   Med: 166.52   Max: 2689.68
Current: 73.38

61.43
2689.68

During the past 6 years, the highest EV-to-Revenue of Biohaven Pharmaceutical Holding Co was 2689.68. The lowest was 61.43. And the median was 166.52.

NYSE:BHVN's EV-to-Revenue is ranked lower than
69% of the 923 Companies
in the Biotechnology industry.

( Industry Median: 22.75 vs. NYSE:BHVN: 73.38 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-04-20), Biohaven Pharmaceutical Holding Co's stock price is $73.650000. Biohaven Pharmaceutical Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $1.07. Therefore, Biohaven Pharmaceutical Holding Co's PS Ratio for today is 69.15.


Biohaven Pharmaceutical Holding Co EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohaven Pharmaceutical Holding Co Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-Revenue Premium Member Only 0.00 0.00 0.00 0.00 80.00

Biohaven Pharmaceutical Holding Co Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,295.80 0.00 0.00 80.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Biohaven Pharmaceutical Holding Co EV-to-Revenue Distribution

* The bar in red indicates where Biohaven Pharmaceutical Holding Co's EV-to-Revenue falls into.



Biohaven Pharmaceutical Holding Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biohaven Pharmaceutical Holding Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4669.501/63.627
=73.39

Biohaven Pharmaceutical Holding Co's current Enterprise Value is $4,669.50 Mil.
Biohaven Pharmaceutical Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was 1.151 (Mar. 2020 ) + 9.698 (Jun. 2020 ) + 17.664 (Sep. 2020 ) + 35.114 (Dec. 2020 ) = $63.63 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Biohaven Pharmaceutical Holding Co  (NYSE:BHVN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biohaven Pharmaceutical Holding Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=73.650000/1.065
=69.15

Biohaven Pharmaceutical Holding Co's share price for today is $73.650000.
Biohaven Pharmaceutical Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.02 (Mar. 2020 ) + 0.165 (Jun. 2020 ) + 0.296 (Sep. 2020 ) + 0.584 (Dec. 2020 ) = $1.07.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Biohaven Pharmaceutical Holding Co EV-to-Revenue Related Terms


Biohaven Pharmaceutical Holding Co EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)